Pam Klein

Title: Pam Klein: Innovator in Breast Cancer Treatment

Introduction

Pam Klein is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of oncology, particularly in the treatment of metastatic breast cancer. With a total of 2 patents, her work focuses on innovative therapies that aim to improve patient outcomes.

Latest Patents

Klein's latest patents revolve around the treatment of previously untreated HER2-positive metastatic breast cancer. The inventions involve a combination of a growth inhibitory HER2 antibody, a HER2 dimerization inhibitor antibody, and a taxane. Specifically, her patents detail the treatment of patients who have not received prior chemotherapy or biologic therapy. The combination therapy includes the administration of trastuzumab, pertuzumab, and docetaxel, which aims to extend the survival of these patients.

Career Highlights

Pam Klein is associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. Her work at Genentech has positioned her as a key player in the development of targeted therapies for cancer treatment.

Collaborations

Klein has collaborated with notable colleagues, including Anne Blackwood Chirchir and Virginia E Paton. These collaborations have further enhanced her research and development efforts in the field of breast cancer treatment.

Conclusion

Pam Klein's contributions to the treatment of metastatic breast cancer highlight her dedication to improving patient care through innovative therapies. Her work continues to inspire advancements in oncology and offers hope to many patients facing this challenging disease.